Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice
The researchers tested abatacept, a drug used for arthritis that modulates T cell response. They found that abatacept reduced Th17 cells in the brain, improved motor function, and protected dopamine-producing nerve cells in the mice.
The researchers tested abatacept, a drug used for arthritis that modulates T cell response. They found that abatacept reduced Th17 cells in the brain, improved motor function, and protected dopamine-producing nerve cells in the mice.